Report on 300 New Medicines in Development for Heart Disease and Stroke Released in In...(at uses a patient's own cells to treat h...),Health

"Pharmaceutical and biotechnology researchers are making exciting progress, but it is wasted if medicines don't get to the patients who need them," says Billy Tauzin, PhRMA's president and CEO. "That is particularly true in these hard economic times with people losing their jobs and health insurance."

Help is available to patients in need through the Partnership for Prescription Assistance (PPA). A clearinghouse for more than 475 patient assistance programs, PPA is sponsored by America's pharmaceutical research companies and has helped more than 5.6 million patients nationwide, including more than 205,475 people in Indiana (contact 1-888-4PPA-NOW or www.pparx.org).

To read the Medicines in Development for Heart Disease and Stroke 2009 on the PhRMA web site, click on the following link: http://www.phrma.org

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

Fo
'/>"/>